Streptococcus pneumoniae (pneumococcus) is a common pathogenic organism causing respiratory and systemic infections in adults and children. To prevent pneumococcal infections, purified polyvalent pneumococcal vaccines have been extensively investigated and their prophylactic efficacy has been suggested, especially in adults (Austrian 1977; Bolan et al. 1986) .
In order to assess specific antibody responses to pneumococcal capsular polysaccharides (PCP), a sensitive enzyme-linked immunosorbent assay (ELISA) has been developed by a number of investigators. ELISA can also be used to determine the levels of specific IgG subclass antibodies to PCP (Barrett and Ayoub 1986; Chudwin et al. 1987; Schatz and Barrett 1987) .
Recently, polyvalent pneumococcal vaccine has been used as a coating antigen in ELISA and such assays are successful in evaluating specific antibodies to PCP antigens (Windebank et al. 1987; Snijder et al. 1988 ). However, it is considered more important to measure the specific IgG2 subclass level in the evaluation of antibody responses to pneumococcal antigens, since IgG antibody to PCP is largely restricted to the IgG2 subclass (Yount et al. 1968; Riesen et al. 1976; Barrett and Ayoub 1986; Schatz and Barrett 1987) .
This article describes a simple ELISA method for quantitating specific IgG subclasses to PCP by using a Pneumovax-specific IgG antibody purified by affinity chromatography as a reference standard and pneumococcal vaccine as a coating antigen.
MATERIALS AND METHODS

Pneumococcal vaccine. A polyvalent pneumococcal vaccine (Pneumovax® ; Merck
Sharp & Dohme, West Point, PA, USA) containing 23 serotypes : 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9v, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F (expressed in Danish nomenclature) was used as coating antigen in ELISA as well as in immunization. Each 0.5 ml dose contained 25pg of polysaccharide from each capsular type of pneumococcus.
Sera. Six healthy adult volunteers were immunized subcutaneously with 0.5 ml of Pneumovax. Sera were collected before immunization, once a week for 4 weeks and at 6 months postimmunization. All samples were stored at -20°C before measurement.
Purification of Pneumovax-specific antibodies. In order to obtain Pneumovax-specific antibodies as a reference standard, affinity chromatography was employed. CNBractivated Sepharose® 4B (Pharmacia LKB Biotechnology AB, Uppsala, Sweden) was swollen and washed with 1 mM HCl on a sintered glass filter. Pneumovax dialysed overnight at 4°C against coupling buffer (0.1 M NaHCO3 ), pH 8.3, containing 0.5 M NaCI, was mixed with the gel, and rotated end-over-end for 2 hr at room temperature. After washing away the excess ligand with coupling buffer, the remaining active sites of the gel were blocked with 1 M ethanolamine, pH 9, for 2 hr room temperature. The product was washed alternately with three cycles of 0.1 M acetate buffer, pH 4, containing 0.5 M NaCI and 0.1 M Tris-HC1 buffer, pH 8, containing 0.5 M NaCI.
Serum from a single healthy donor collected one month after immunization with Pneumovax was precipitated with the same volume of ammonium sulfate. After centrifugation, the precipitate was redissolved in 0.01 M phosphate-buffered saline (PBS), pH 7.4, to the same volume as that of the original serum, and dialysed against PBS overnight at 4°C. This ammonium sulfate-precipitated serum was passed slowly through the gel coupled with Pneumovax collected in a plastic tube, and Pneumovax-specific antibodies were then eluted with 3 M NaSCN, pH 7.4.
Monoclonal antibodies to human IgG subclasses. Mouse monoclonal antibodies to human IgGI (HP6069), IgG2 (HP6014), IgG3 (HP6050) and IgG4 (HP6011) were kindly donated by the World Health Organization (WHO). In the present study, anti-human IgGI, IgG2 and IgG4 were diluted 1:1000 and IgG3 was diluted 1: 500 in 0.01 M PBS containing 0.05% Tween-20 (PBS-Tween).
ELISA. Before quantitating Pneumovax-specific IgG subclass antibodies, each IgG subclass level in the purified solution containing Pneumovax-specific antibodies was measured quantitatively by the previously described ELISA technique (Ishizaka et al. 1989 When measuring Pneumovax-specific IgGI and IgG2 concentrations in each test serum, the plates were coated with a 1:10 dilution of Pneumovax, and the purified solution containing Pneumovax-specific antibodies was used as a reference standard in this ELISA method. All sera were measured twice and values were averaged.
RESULTS
Purified Pneumovax-specifc antibodies. Pneumovax-specific antibodies were purified by means of affinity chromatography. Serum was collected from a single healthy adult one month after immunization with Pneumovax, and was precipitated using ammonium sulfate. Then, the precipitate diluted in PBS was passed through an affinity column containing CNBr-activated Sepharose 4B coupled with Pneumovax (effluent). Pneumovax-specific antibodies were TABLE 1. Immunoglobulin class and subclass levels during purification of Pneumovaxspecific antibodies obtained by elution (eluate). In these four samples (the original serum, the precipitated serum, the effluent and the eluate), the concentrations of immunoglobulin classes and IgG subclasses were measured by ELISA ( Table 1) . The results showed an extreme change in the constituent ratio of IgG subclasses in the eluate. The three other samples had almost the same constituent ratio, that is, the IgGi subclass antibody was predominant. In contrast, the ratio of IgGl/IgG2 was clearly inverted in the eluate, which contained IgGi : 39 ,u g/ml, IgG2: 193 /4g/ml and IgG3 : 119 ng/ml. IgG4 was not detected by this ELISA method.
In order to rule out the possibility of contamination with nonspecific antibodies in the eluate, ammonium sulfate-precipitated serum was passed through the other amity column containing CNBr-activated Sepharose 4B not coupled with ligands. The eluate obtained from this affinity column contained no antibodies.
Quantitation of IgG subclasses to Pneumovax by ELISA. Using the purified specific antibodies to Pneumovax as a reference standard, Pneumovax-specific IgG subclasses in the pre-and post-immunized sera were measured quantitatively by ELISA. Fig. l shows the standard curves of IgGl end IgG2 created from serial dilutions of the purified specific antibodies. Correlation coefficients between the absorabances and the antibody concentration in the linear portion were 0.995 and 0.998, respectively.
Before immunization, the mean concentrations of IgGl-3 subclass antibodies were 2.6 ,u g/ml (ranging from 1.9 ,u g/ml to 5.1 ,u g/ml ), 53.0 ,u g/ml (17.7-94.2 1ug/ ml) and 1.7ng/ml (1.2-2.6 ng/ml), respectively. Peak levels were observed 2 to 4 weeks after immunization. There was a remarkable increase in the mean concentration of IgG2 (478.7 ,u g/ml ; ranging from 340.7 ,u g/ml to 709.01u g/ml) except in one volunteer (78.6 ,u g/ml ), in contrast to those of IgG 1 (23.8 ,u g/ml ; 4.2-40.2 Correlation coefficients between the absorbance and the antibody concentration in the linear portion were 0.995 and 0.998, respectively. jug/ml) and IgG3 (64.0 ng/ml ; 46.1-84.4 ng/ml). As seen in Fig. 2 , the antibody response of the IgG2 subclass to Pneumovax was extremely remarkable in comparison with that of IgGI. Pneumovax-specific IgGI and IgG2 levels in sera six months post-immunization were higher than those of before immunization.
DISCUSSION
Following the availability of prophylactic vaccination against pneumococcal infections, several methods have been developed to assess antibody responses to pneumococcal capsular polysaccharides (PCP). Of those methods, the radioimmunoassay (RIA) and enzyme-linked immunosorbent assay (ELISA) are currently available, and estimated to be highly specific and sensitive. Immunoglobulin classes and subclasses directed to PCP have been measured quantitatively by RIA, and expressed as antibody nitrogen per ml Chudwin et al. 1987 ). However, the RIA procedure is unable to be applied in every laboratory because of the need for use of a radioactive isotope. Recently ELISA has been applied to measure the levels of specific antibodies against PCP because this procedure is simple, rapid and in addition, suitable for many laboratories.
In order to measure quantitatively immunoglobulin calss and subclass antibodies against PCP, several modifications of the ELISA method have been attempted.
However, technical problems in the procedure seem to make it difficult to quantitate specific antibodies to PCP. In our present study, IgG subclass antibody responses to a polyvalent pneumococcal vaccine (Pneumovax) were assessed by quantitative ELISA, using purified Pneumovax-specific antibodies as a reference standard. Comparisons of direct optical density (OD) readings within a single assay are practical but not on different days. Moreover, it is technically difficult to evaluate differences of each IgG subclass response to PCP on a quantitative basis even within a single assay. In our study, the mean peak level of IgG2 in the post-immunization serum was less than twice as much as that of IgGI, when expressed as raw OD values (data not shown). However, the results from quantitative ELISA showed a twenty-fold difference between the mean peak levels of IgGI and IgG2 in post-immunization sera except in one low responder (Fig. 2) . We have developed an easier method for quantitative analysis of Pneumovax-specific IgG subclasses by using purified IgG antibodies to Pneumovax as a reference standard. When measured by this ELISA method, all healthy volunteers except one showed a good response to immunization with Pneumovax, and IgG subclass antibody directed against Pnnumovax was predominantly IgG2. On the other hand, using human myelomas of a difined IgG subclass as a reference serum standard, Schatz and Barrett (1987) measured IgG subclasses to pneumococcal polysaccharide type 3 after immunization in children, expressing values quantitatively in ng/ml. In their study, there was no significant difference in the level of IgGI antibody to type 3 between age groups, but profound age-dependent changes in IgG2 antibody concentration were noted. These results indicate that IgG antibody to PCP is largely restricted to the IgG2 subclass, and are in agreement with previous studies (Yount et al. 1968 ; Riesen et al. 1976; Siber et al. 1980; Barrett and Ayoub 1986) .
In one exceptional case in our study the peak concentration of specific IgG2 subclass was below 100 ,u g/ml. This suggests that there are poor responders to PCP antigens. Sarvas et al. (1989) demonstrated that after vaccination with a 23-valent pneumococcal polysaccharide vaccine, allotype G2m(n)-positive homozygotes had about four times more IgG2 antibodies (anti-14 and anti-18C) than did G2m(n)-negative vaccinated individuals, and heterozygotes occupied an intermediate position, which suggested codominant inheritance of the G2m(n)associated strong responsiveness. If their hypothesis is accepted, our poor responder may be a G2m(n)-negative homozygote or heterozygote. To clarify this, however, would require more investigation.
